STOCK TITAN

Clovis Oncology to Announce First Quarter 2022 Financial Results and Host Webcast Conference Call on May 4

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Clovis Oncology will release its first quarter 2022 financial results on May 4, 2022, prior to the US market opening. A conference call, including a live audio webcast, will occur at 8:30am ET for detailed discussions on results. Interested parties can access the webcast on the Clovis Oncology website, with a replay available for 30 days. Investors can participate by calling 888.440.4615 for US and 646.960.0682 for international attendees, using conference ID 2259685.

Positive
  • None.
Negative
  • None.

BOULDER, Colo.--(BUSINESS WIRE)-- Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its first quarter 2022 financial results on Wednesday, May 4, 2022, before the open of the US financial markets. Clovis’ senior management will host a conference call and live audio webcast at 8:30am ET to discuss the Company’s results in greater detail.

The conference call will be simultaneously webcast on the Clovis Oncology website www.clovisoncology.com, and a replay of the webcast will be available for 30 days.

Dial-in numbers for the conference call are as follows: US participants 888.440.4615, International participants 646.960.0682, conference ID: 2259685.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the US, Europe, and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops with partners diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado; please visit www.clovisoncology.com for more information, including additional office locations in the US and Europe.

Clovis Investor Contacts:

Anna Sussma

303.625.5022

asussman@clovisoncology.com

Breanna Burkart

303.625.5023

bburkart@clovisoncology.com

Source: Clovis Oncology, Inc.

FAQ

When will Clovis Oncology announce its first quarter 2022 financial results?

Clovis Oncology will announce its first quarter 2022 financial results on May 4, 2022.

What time is the Clovis Oncology conference call?

The Clovis Oncology conference call is scheduled for 8:30am ET on May 4, 2022.

How can I access the Clovis Oncology financial results webcast?

You can access the Clovis Oncology financial results webcast on their website at www.clovisoncology.com.

What is the conference ID for Clovis Oncology's call?

The conference ID for Clovis Oncology's call is 2259685.

Will the Clovis Oncology conference call be available for replay?

Yes, a replay of the Clovis Oncology conference call will be available for 30 days after the event.

CLVS

NASDAQ:CLVS

CLVS Rankings

CLVS Latest News

CLVS Stock Data

11.77M
142.86M
1.44%
25.9%
19.65%
Biotechnology
Healthcare
Link
United States
Boulder